Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism

NCT00745030 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Low subject recruitment and enrollment.

Conditions

REM Behavior Disorder
Parkinsonism

Interventions

DRUG: Rozerem
DRUG: Placebo

Sponsor

Northwestern University

Collaborators

[object Object]